Living Cell Technologies Limited
Talk to Living Cell Technologies Limited directly.
Sign up to their Investor Hub for direct access to the Living Cell Technologies Limited team, ask them questions, and see personal updates.
Living Cell Technologies (LCT) develops cell therapies to treat diseases with high unmet clinical needs. The Australasian biotechnology company is a global pioneer in the field of cell encapsulation and implantation for human therapeutics. To date, the company has taken two therapeutic candidates into clinical development: DIABECELL for the treatment of type 1 diabetes and NTCELL , which is in Phase I clinical trials in New Zealand for the treatment of Parkinson's disease. Former Names --
Level 7/330 Collins St, Melbourne VIC 3000, Australia
Earnings per share
Dividend per share